Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
SOLESENCE Aktie jetzt für 0€ handeln | |||||
Di | SOLESENCE, INC. - 10-Q, Quarterly Report | 4 | SEC Filings | ||
07.05. | SOLESENCE, INC. - 8-K, Current Report | 7 | SEC Filings | ||
05.05. | Nanophase Technologies GAAP EPS of $0.00, revenue of $14.63M | 7 | Seeking Alpha | ||
07.04. | SOLESENCE, INC. - 8-K, Current Report | 20 | SEC Filings | ||
07.04. | Solésence moves to Nasdaq with new ticker SLSN | 7 | Investing.com | ||
07.04. | Solésence wechselt zur NASDAQ mit neuem Tickersymbol SLSN | 14 | Investing.com Deutsch | ||
07.04. | Solésence, Inc.: Solésence Announces Uplisting to Nasdaq | 777 | GlobeNewswire (Europe) | Trading set to begin Tuesday, April 8 under new ticker "SLSN" ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions... ► Artikel lesen | |
07.04. | SOLESENCE, INC. - 8-A12B, Registration of securities | 3 | SEC Filings | ||
31.03. | NANOPHASE TECHNOLOGIES Corp - 10-K, Annual Report | 7 | SEC Filings | ||
27.03. | Nanophase targets record Q1 2025 revenue with 33% gross margins amid heightened demand | 9 | Seeking Alpha | ||
26.03. | NANOPHASE TECHNOLOGIES Corp - 8-K, Current Report | 3 | SEC Filings | ||
26.03. | Solésence, Inc.: Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results | 469 | GlobeNewswire (Europe) | Fourth quarter revenue increased 58% to a record $12.6 million Full Year 2024 revenue increased 40% to a record $52.3 million ROMEOVILLE, Ill., March 26, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB:... ► Artikel lesen | |
26.03. | Solésence GAAP EPS of -$0.01, revenue of $12.57M | 31 | Seeking Alpha | ||
13.03. | Solésence, Inc.: Solésence Wins Best Prestige Finished Formula at the 2025 Cosmetics & Toiletries Alle Awards, Marking Third Consecutive Win | 19 | GlobeNewswire (USA) | ||
12.03. | Solésence, Inc.: Solésence Launches New Investor Relations Website | 10 | GlobeNewswire (USA) | ||
12.03. | NANOPHASE TECHNOLOGIES Corp - 8-K, Current Report | 8 | SEC Filings | ||
07.03. | Nanophase Technologies Rebrands as Solésence, Elevating the Future of Skin Health | 558 | GlobeNewswire (Europe) | ROMEOVILLE, Ill., March 07, 2025 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life... ► Artikel lesen | |
16.01. | NANOPHASE TECHNOLOGIES Corp - 8-K, Current Report | 7 | SEC Filings | ||
30.10.24 | Nanophase Technologies Corporation: Nanophase Reports Record Third Quarter Revenue and Profit | 801 | GlobeNewswire (Europe) | -Nanophase Reports Q3 Revenue Record at $16.9 Million with Solésence Revenue up 171% YOY? -Record $3 Million in Q3 Profit ROMEOVILLE, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies... ► Artikel lesen | |
06.08.24 | Nanophase Technologies Corporation: Nanophase Reports Record Second Quarter Revenue and Profit | 493 | GlobeNewswire (Europe) | -$13 Million in Q2 Revenue, with Solésence Revenue up 44% YOY -$1.7 Million in Profit?for the First Half of 2024 alongside Record Q2 Profit -Record Third Win in a Row at Cosmoprof and Cosmopack North... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 23,000 | -0,86 % | Formycon-Aktie: Kurs fällt ab (23,90 €) | An der deutschen Börse notiert das Wertpapier von Formycon derzeit ein wenig leichter. Der jüngste Kurs betrug 23,90 Euro. Für die Aktie von Formycon steht gegenwärtig ein Abschlag von 2,65 Prozent... ► Artikel lesen | |
ONTO INNOVATION | 91,50 | -2,14 % | Onto Innovation: Chancen und Risiken einer dynamischen Aktie | ||
GAUZY | 8,880 | 0,00 % | Gauzy GAAP EPS of -$0.58, revenue of $22.4M | ||
VEECO INSTRUMENTS | 19,100 | 0,00 % | Breaking Down Veeco Instruments: 7 Analysts Share Their Views | ||
NANOFORM FINLAND | 0,942 | -1,57 % | Nanoform Finland Oyj: Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc | Company release
Nanoform Finland Plc
April 15, 2025
14.10 Finnish time / 13.10 Swedish time
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Nanoform Finland... ► Artikel lesen | |
DOTZ NANO | 0,045 | -3,23 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
FENDX TECHNOLOGIES | 0,049 | +2,49 % | FendX Technologies Inc.: FendX Announces Share Issuance Pursuant to IP License Agreement | Oakville, Ontario--(Newsfile Corp. - May 5, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection... ► Artikel lesen | |
KOPIN | 1,271 | +1,68 % | KOPIN CORP - 10-Q, Quarterly Report | ||
OBDUCAT | 0,055 | -8,33 % | NGM MARKET NOTICE: #25-43 Information regarding the last day of trading in paid subscribed shares issued by Obducat AB | ||
ACACIA RESEARCH | 3,200 | 0,00 % | ACACIA RESEARCH CORP - 10-Q, Quarterly Report | ||
ADVANCE ZINCTEK | 0,434 | -0,46 % | ADVANCE ZINCTEK LIMITED: Business Update | ||
LEHNER INVESTMENTS | 0,035 | 0,00 % | EQS-Adhoc: LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet | EQS-Ad-hoc: LEHNER INVESTMENTS AG / Schlagwort(e): Rechtssache
LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet
04.04.2025 / 18:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
NANOFOCUS | 1,180 | 0,00 % | NanoFocus schließt Kapitalerhöhung ab | Die NanoFocus AG hat die beschlossene Kapitalerhöhung gegen Sach- und Bareinlagen durchgeführt. Insgesamt wurden 6.021.664 neue Aktien zu je 1,00 Euro ausgegeben. Davon gingen 4.276.884 Aktien an die... ► Artikel lesen | |
RIBER | 2,830 | -1,05 % | Australian National Fabrication Facility orders Riber MBE 412 cluster platform | ||
NANOVIRICIDES | 1,040 | 0,00 % | NanoViricides: Measles Cases Are Increasing Globally; MPox Continues to Be a Threat - Broad-Spectrum Antiviral Drug Could Be the Solution | NanoViricides Explains Its Drug Strategy for Combating Viral Infections and Pandemics SHELTON, CT / ACCESS Newswire / May 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC)... ► Artikel lesen |